Literature DB >> 2414938

Conformational changes in influenza virus haemagglutinin and its monomer detected by monoclonal antibodies.

A N Nestorowicz, D O White, D C Jackson.   

Abstract

Exposure of influenza virus haemagglutinin to pH 5 results in conformational changes occurring in the molecule which are accompanied by antigenic modifications. Furthermore, isolated haemagglutinin (HA) at a concentration of 0.1 nM undergoes dissociation from the trimeric to a monomeric form when exposed to pH 5. Whether present on intact virus or as the isolated monomer, each form of haemagglutinin from pH 5 exhibits similar alterations in antigenic characteristics. These forms of HA show modifications in the antigenic sites located in the hinge (site C), tip (site B) and subunit interface (site D) regions. Whereas binding of monoclonal antibodies recognizing the tip and interface is abrogated or diminished, binding of antibodies to the hinge region is greatly enhanced following exposure of virus or the monomeric form of HA to pH 5.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414938     DOI: 10.1016/0264-410x(85)90099-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Activation of fusion by the SER virus F protein: a low-pH-dependent paramyxovirus entry process.

Authors:  Shaguna Seth; Annelet Vincent; R W Compans
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2.

Authors:  F Kostolansky; G Russ; V Mucha; B Styk
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 3.  Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk.

Authors:  Charles J Russell; Meng Hu; Faten A Okda
Journal:  Trends Microbiol       Date:  2018-04-19       Impact factor: 17.079

4.  Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin.

Authors:  William C Weldon; Bao-Zhong Wang; Maria P Martin; Dimitrios G Koutsonanos; Ioanna Skountzou; Richard W Compans
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.